These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17566621)

  • 1. Creating knowledge about adverse drug reactions: a critical analysis of the Danish reporting system from 1968 to 2005.
    Aagaard L; Soendergaard B; Andersen E; Kampmann JP; Hansen EH
    Soc Sci Med; 2007 Sep; 65(6):1296-309. PubMed ID: 17566621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of the capture-recapture method to assess the frequency of "serious" adverse drug reactions: experience of Toulouse University Hospital].
    Montastruc JL; Lugardon S; Desboeuf K; Fernet P; Lapeyre-Mestre M
    Bull Acad Natl Med; 2008 Feb; 192(2):421-30; discussion 430-1. PubMed ID: 18819693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a capture-recapture method to assess the frequency of adverse drug reactions in a French university hospital.
    Lugardon S; Desboeuf K; Fernet P; Montastruc JL; Lapeyre-Mestre M
    Br J Clin Pharmacol; 2006 Aug; 62(2):225-31. PubMed ID: 16842398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of drug safety information using large-scale adverse drug reactions database].
    Morikawa K
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2011; (129):1-26. PubMed ID: 22259840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reporting of adverse drug reactions in Iceland in 1999 to 2004].
    Jóhannsson M; Agústsdóttir E
    Laeknabladid; 2006 Apr; 92(4):283-7. PubMed ID: 16582456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions of antidepressants and antipsychotics: experience, knowledge and attitudes among Norwegian psychiatrists.
    Castberg I; Reimers A; Sandvik P; Aamo TO; Spigset O
    Nord J Psychiatry; 2006; 60(3):227-33. PubMed ID: 16720514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurses are increasingly involved in pharmacovigilance in Sweden.
    Ulfvarson J; Mejyr S; Bergman U
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):532-7. PubMed ID: 17072915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods.
    Lin SF; Xiao KT; Huang YT; Chiu CC; Soo VW
    Artif Intell Med; 2010; 48(2-3):161-6. PubMed ID: 19962282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley.
    Jha N; Bajracharya O; Namgyal T
    Kathmandu Univ Med J (KUMJ); 2007; 5(4):504-10. PubMed ID: 18604084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years of adverse drug reaction reports for the multiple sclerosis immunomodulatory therapies: a Canadian perspective.
    Tremlett HL; Oger J
    Mult Scler; 2008 Jan; 14(1):94-105. PubMed ID: 17881392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adapting a commercially available software program to improve ADR reporting.
    Ries AJ; Kraynak MA
    Formulary; 1995 Nov; 30(11):697-8, 703-4. PubMed ID: 10152873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and attitudes of healthcare professionals in Wuhan, China to the reporting of adverse drug reactions.
    Li Q; Zhang SM; Chen HT; Fang SP; Yu X; Liu D; Shi LY; Zeng FD
    Chin Med J (Engl); 2004 Jun; 117(6):856-61. PubMed ID: 15198887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reactions reporting by physicians in Ibadan, Nigeria.
    Okezie EO; Olufunmilayo F
    Pharmacoepidemiol Drug Saf; 2008 May; 17(5):517-22. PubMed ID: 18404621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the spontaneous reporting of adverse drug reactions--the experience of the Slovak Republic.
    Tisonová J; Szalayová A; Kriska M; Gibala P; Foltán V
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):333-7. PubMed ID: 15133786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: a comparison regarding patients and drugs.
    Egberts AC; de Koning FH; Meyboom RH; Leufkens HG
    Pharmacoepidemiol Drug Saf; 1997 Jul; 6(4):269-76. PubMed ID: 15073778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.